Table 2.
Symptoms and complications in G1 and G2 patients
| Symptoms | G1 | G2 | |
|---|---|---|---|
| COVID-19 pneumonia | 388 | 0 | |
| Dyspnea | 338 | 4 | |
| Fever | 369 | 152 | Χ21 = 262,p < 2.2e-06 |
| Myalgia/bone pain | 259 | 95 | Χ21 = 136.64,p < 2.2e-06 |
| Cough | 254 | 88 | Χ21 = 141,p < 2.2e-06 |
| Dysgeusia | 190 | 125 | Χ21 = 22.05,p = 2.6e-06 |
| Parosmia | 164 | 124 | Χ21 = 8.58,p = 0.003 |
| Headache | 156 | 60 | Χ21 = 58,p < 2.2e-06 |
| Diarrhea | 122 | 38 | Χ21 = 54.41,p < 2.2e-06 |
| Runny nose | 101 | 57 | Χ21 = 14.87,p=0.0001 |
| Gastroenteritis/abdominal pain | 105 | 17 | Χ21 = 73.8,p < 2.2e-06 |
| Throat pain | 63 | 32 | Χ21 = 10.92,p=0.0009 |
| Conjunctivitis | 54 | 32 | Χ21 = 5.87,p=0.015 |
| Complications | G1 | G2 | |
| Fatigue | 347 | 137 | |
| Exertional dyspnea | 150 | 1 | |
| CNS-general | 68 | 4 | |
| CNS-cognitive | 68 | 0 | |
| Cardiovascular-arrhythmias | 37 | 1 | |
| CNS-psychiatric | 31 | 0 | |
| Cardiovascular-blood pressure | 24 | 0 | |
| Pulmonary embolism | 23 | 0 | |
| Respiratory-ARDS | 22 | 0 | |
| Thromboembolism-other | 20 | 0 | |
| Kidney-ARI | 19 | 0 | |
| Skin-alopecia | 18 | 0 | |
| PNs-sensory | 18 | 0 | |
| Respiratory-pneumothorax | 16 | 0 | |
| PNs-motor | 8 | 0 | |
| Skin-erythema | 8 | 0 | |
| Endocrine-thyroid | 5 | 0 | |
| Cardiovascular-pericarditis | 5 | 0 | |
| Cardiovascular-arrest | 3 | 0 | |
| Cardiovascular-AMI | 3 | 0 | |
| Cardiovascular-phlebitis | 3 | 0 | |
| Endocrin-new T2DM | 2 | 0 | |
| Skin-psoriasis | 1 | 0 | |
| Cardiovascular-heart failure | 1 | 0 | |
| Kidney-NS | 1 | 0 |
The last column contains the chi-squared test (Χ2n, with n degree of freedom); the statistical tests were performed on the variables that were not directly used for the case-control matching procedure. CNS, central nervous system (CNS) related symptoms; Cardiovascular, cardiovascular disorders; Respiratory, respiratory system disorders; ARDS, acute respiratory distress syndrome; Thromboembolism-other, non-pulmonary thromboembolic events; Kidney, renal disorders; ARI, acute renal insufficiency; Skin, skin disorders; PNs, peripheral neuropathy predominantly sensory or motor; Endocrine, endocrine disorders; Thyroid; thyroid dysfunction; AMI, acute myocardial infarction; new T2DM, new onset type 2 diabetes mellitus; NS, nephrotic syndrome.